EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 307 filers reported holding EXELIXIS INC in Q4 2017. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,593 | -18.0% | 1,034 | -28.3% | 0.00% | – |
| Q2 2023 | $27,557 | -49.0% | 1,442 | -57.4% | 0.00% | -100.0% |
| Q3 2022 | $54,000 | -26.0% | 3,385 | -3.3% | 0.00% | 0.0% |
| Q2 2022 | $73,000 | -23.2% | 3,502 | -16.3% | 0.00% | 0.0% |
| Q1 2022 | $95,000 | +216.7% | 4,182 | +236.7% | 0.00% | 0.0% |
| Q3 2020 | $30,000 | -42.3% | 1,242 | -42.9% | 0.00% | -50.0% |
| Q2 2020 | $52,000 | +5100.0% | 2,174 | +6912.9% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 31 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 31 | -50.0% | 0.00% | – |
| Q3 2019 | $1,000 | -90.9% | 62 | -87.5% | 0.00% | – |
| Q2 2019 | $11,000 | -98.7% | 497 | -98.9% | 0.00% | -100.0% |
| Q4 2018 | $856,000 | +10.6% | 43,525 | -0.4% | 0.04% | -7.3% |
| Q3 2018 | $774,000 | -17.7% | 43,678 | 0.0% | 0.04% | -47.4% |
| Q2 2018 | $940,000 | +110.3% | 43,678 | +116.5% | 0.08% | +32.2% |
| Q1 2018 | $447,000 | -31.0% | 20,178 | -5.3% | 0.06% | -35.9% |
| Q4 2017 | $648,000 | – | 21,300 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |